{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:44:51Z","timestamp":1740120291871,"version":"3.37.3"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Edward Blank and"},{"name":"Sharon Cosloy-Blank Family Foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.eururo.2019.04.003","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T18:06:11Z","timestamp":1557252371000},"page":"467-468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Overactive Surveillance: Is \u201cConservative\u201d Management for Low-risk Prostate Cancer Too Aggressive?"],"prefix":"10.1016","volume":"76","author":[{"given":"Stacy","family":"Loeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2019.04.003_bib0055","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","article-title":"Long-term follow-up of a large active surveillance cohort of patients with prostate cancer","volume":"33","author":"Klotz","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2019.04.003_bib0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/jama.2015.6036","article-title":"Trends in management for patients with localized prostate cancer, 1990\u20132013","volume":"314","author":"Cooperberg","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2019.04.003_bib0065","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2019.04.003_bib0070","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1200\/JCO.2015.62.5764","article-title":"Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer","volume":"33","author":"Tosoian","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2019.04.003_bib0075","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.eururo.2017.07.018","article-title":"Active surveillance versus watchful waiting for localized prostate cancer: a model to inform decisions","volume":"72","author":"Loeb","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2019.04.003_bib0080","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bju.14106","article-title":"The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date","volume":"121","author":"Bruinsma","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2019.04.003_bib0085","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.eururo.2018.10.025","article-title":"Reasons for discontinuing active surveillance: assessment of 21 centres in 12 countries in the Movember GAP3 consortium","volume":"75","author":"Van Hemelrijck","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2019.04.003_bib0090","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.eururo.2019.02.035","article-title":"The value of an extensive transrectal repeat biopsy with anterior sampling in men on active surveillance for low-risk prostate cancer: a comparison from the Randomised Study of Active Monitoring in Sweden (SAMS)","volume":"76","author":"Bratt","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2019.04.003_bib0095","first-page":"e144","article-title":"Prostate Health Index and multiparametric magnetic resonance imaging to predict prostate cancer grade reclassification in active surveillance","volume":"188","author":"Schwen","year":"2018","journal-title":"J Urol Suppl"},{"key":"10.1016\/j.eururo.2019.04.003_bib0100","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.eururo.2015.03.023","article-title":"Precision medicine in active surveillance for prostate cancer: development of the Canary-Early Detection Research Network active surveillance biopsy risk calculator","volume":"68","author":"Ankerst","year":"2015","journal-title":"Eur Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283819302829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283819302829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T11:44:52Z","timestamp":1569239092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283819302829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0302283819302829"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2019.04.003","relation":{},"ISSN":["0302-2838"],"issn-type":[{"type":"print","value":"0302-2838"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overactive Surveillance: Is \u201cConservative\u201d Management for Low-risk Prostate Cancer Too Aggressive?","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2019.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2019.02.035","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}